Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Princiotta

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Experimental Medicine|June 13, 1998
H2-M3 restricted presentation of a Listeria-derived leader peptideM F Princiotta, L L Lenz, M J Bevan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
A physiological ligand of positive selection is recognized as a weak agonistR E Berg, S Irion, S Kattman, et al.
Immunity|August 6, 1999
Positive selection of an H2-M3 restricted T cell receptorR E Berg, M F Princiotta, S Irion, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2001
Cells adapted to the proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survivalM F Princiotta, U Schubert, W Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2001
Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivoC C Norbury, M F Princiotta, I Bacik, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2000
Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2U Schubert, D E Ott, E N Chertova, et al.
The Journal of Cell Biology|July 14, 1999
Intracellular localization of proteasomal degradation of a viral antigenL C Antón, U Schubert, I Bacík, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Experimental Medicine|June 13, 1998
H2-M3 restricted presentation of a Listeria-derived leader peptideM F Princiotta, L L Lenz, M J Bevan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 18, 2000
A physiological ligand of positive selection is recognized as a weak agonistR E Berg, S Irion, S Kattman, et al.
Immunity|August 6, 1999
Positive selection of an H2-M3 restricted T cell receptorR E Berg, M F Princiotta, S Irion, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2001
Cells adapted to the proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone require enzymatically active proteasomes for continued survivalM F Princiotta, U Schubert, W Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2001
Multiple antigen-specific processing pathways for activating naive CD8+ T cells in vivoC C Norbury, M F Princiotta, I Bacik, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2000
Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2U Schubert, D E Ott, E N Chertova, et al.
The Journal of Cell Biology|July 14, 1999
Intracellular localization of proteasomal degradation of a viral antigenL C Antón, U Schubert, I Bacík, et al.
Pageof 1